# Summit Therapeutics Inc.: Form SC 13D/A, filed Sep 13, 2024

- Company: [Summit Therapeutics Inc.](/companies/smmt.md) (CIK 1599298)
- Form: SC 13D/A
- Filed: 2024-09-13
- Accepted by EDGAR: Sep 13, 2024, 17:54 ET
- Period: not reported
- Accession: 0001193125-24-218980
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1599298/000119312524218980/d868966dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1599298/000119312524218980/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1599298/000119312524218980/d868966dsc13da.htm

Filed Sep 13, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-218980. Last ingested by Listed: Nov 4, 2026, 19:36 ET. No prices; not investment advice.